MR编号 | SE/H/0229/003 |
---|
药品名称 | Symbicort |
---|
活性成分 | - Budesonide 160.0 µg/dose
- Formoterol fumarate 4.5 µg/dose
|
---|
剂型 | Pressurised inhalation, suspension |
---|
上市许可持有人 | AstraZeneca AB
Sweden |
---|
参考成员国 - 产品名称 | Sweden (SE) |
---|
互认成员国 - 产品名称 | - Denmark (DK)
- Belgium (BE)
- Netherlands (NL)
- Luxembourg (LU)
- Iceland (IS)
- United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
- France (FR)
- Spain (ES)
- Portugal (PT)
- Italy (IT)
- Greece (GR)
- Norway (NO)
- Finland (FI)
- Poland (PL)
- Latvia (LV)
Symbicort 160 mikrogrami/4,5 mikrogrami/izsmidzinājumā, aerosols inhalācijām, zem spiediena, suspensija - Lithuania (LT)
Symbicort Turbuhaler 160 µg/4,5 µg/išpurškime suslėgtoji įkvepiamoji suspensija - Estonia (EE)
- Hungary (HU)
- Bulgaria (BG)
Symbicort - Cyprus (CY)
- Czechia (CZ)
- Romania (RO)
Symbicort 160 micrograme/4,5 micrograme/inhalație suspensie de inhalat presurizată - Slovakia (SK)
- Slovenia (SI)
- Malta (MT)
- Croatia (HR)
|
---|
许可日期 | 2016/03/03 |
---|
最近更新日期 | 2024/11/22 |
---|
药物ATC编码 | - R03AK07 formoterol and budesonide
|
---|
申请类型 | - TypeLevel1:Line Extension
- TypeLevel2:Initial Application
- TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|